Complementary insights: Exploring the dual analysis of circulating tumour cells and circulating DNA

A melanoma brain metastasis CTC signature and CTC:B cell clusters associate with secondary liver metastasis: a melanoma brain-liver metastasis axis

Digoxin for reduction of circulating tumour cell cluster size in metastatic breast cancer

SABCS: A novel, semi-automated Pipeline for HER2 Quantification on CTCs in breast cancer patients. Is cytopathology of peripheral blood a new diagnostic option?

CIRCUS: CIRCUlating tumour cells in soft tissue Sarcoma – a short report

Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment

Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer

Low‑pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple‑negative breast cancer

Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations

Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium

Request a meeting with